Patent · US Active

Quinazolinedione derivatives as PARP inhibitors

US8623884B2 · kind B2 · utility

0Cited by

19References

9Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Ludo Edmond Josephine Kennis · Lier, BE
Josephus Carolus Mertens · Oud-Turnhout, BE
Jacobus Alphonsus Josephus Van Dun · Kasterlee, BE
Maria Victorina Francisca Somers · Vosselaar, BE
Walter Boudewijn Leopold Wouters · Kapellen, BE

Key dates

Filing date	Nov 17, 2011
Grant date	Jan 7, 2014
Priority date	—
Expiry date	Jan 5, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds of formula (I), their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds of formula (I)wherein R1, L1, L2, X, Y and Z have defined meanings.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.